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ABSTRACT 
Objective: To assess the prescription quality in a comprehensive geriatric clinic and to determine the frequency of inappropriate prescription and 
polypharmacy. 
Methods: Both males and female patients above the age of 60 y attending a comprehensive geriatric clinic of a tertiary care hospital were included 
in the study. Medications taken by the patients, excluding vitamins, minerals and herbal medications were counted in each patient and analyzed by 
considering their medical history and using universally accepted tools like medication appropriateness index, START, STOPP & Beer’s criteria. In 
this study, polypharmacy was considered as having 6 or more medications per prescription.  
Results: A total of 120 patients were included in the study. Around 82 (68.33%) patients had less than 6 prescribed medications and 38 patients 
(31.66%) were on 6 or more than 6 medications. The number of medications used by the patients is 4.37±2.33. Around 21 (17.5%) were on 
medications that are not indicated, 25 patients (20.83%) were receiving medications which are to be avoided in elderly as per the Beer’s and STOPP 
criteria. Medication was underused in 24 patients (20%) as per START criteria. When both overused drugs and drugs to be avoided were 
considered for assessment of inappropriateness, 39 patients (32.5%) were found to be receiving inappropriate medication. Among the drugs to be 
avoided in elderly, amitriptyline was the most common drug and was used in 15 (12.5%) patients. Antihypertensives were the most common 
potential prescribing omissions in geriatric patients. 
Conclusion: Polypharmacy is seen in a significant proportion of geriatric patients. Inappropriate prescription and potential prescribing omissions 
were observed in a significant proportion of geriatric patients.  
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INTRODUCTION 
Appropriate prescribing is the outcome of the process of decision-
making that maximises net individual health gains within the 
society’s available resources’ [1]. The use of medication can be 
considered appropriate if it has potential benefits outweighing the 
potential risks. Failure to prescribe drugs when it is indicated (act of 
omission) or prescribing drugs that are contraindicated (act of 
commission) are the examples of inappropriate prescription [2]. The 
polypharmacy i. e, the use of more than six medications is a serious 
problem in the present health care system, especially in the geriatric 
population. There is no consensus on the definition of 
polypharmacy. The terms ‘polypharmacy’ and ‘inappropriate drug 
use’ were used interchangeably in the literature [3]. 
The prescriptions can be evaluated for their appropriateness using 
the process or outcome that may be implicit (judgment-based) or 
explicit (criterion-based) measures. Process measures assess 
whether the prescription is in line with the accepted standards. In 
the geriatric population, explicit indicators of appropriate 
prescribing were developed based on extensive literature reviews 
and expert opinions which are drug or disease-oriented. These 
require a little clinical judgment, are too rigid and do not sufficiently 
address the comorbidities. Whereas in implicit measures, the 
information from the patient as well as from the medical literature 
was used to make judgments regarding appropriateness. Here, the 
focus is usually on the patient rather than on a specific drug. These 
are most sensitive, consider patient preferences, but are time-
consuming. It depends on the knowledge and attitudes of the user 
and likely to have low inter-rater variability [4].  
Evaluation of the quality of health care, especially in geriatrics is 
gaining more importance in the recent years. Longer life expectancy, 
comorbidities and the use of evidence-based clinical practice 
guidelines are responsible for increasing polypharmacy in the 
elderly population. Prescribing cascade i. e, medication resulting in 
an adverse drug reaction that is treated with another medication, 
could be one of the factors involved in polypharmacy [5]. With the 
increased number of prescription drugs, there are more chances of 
inappropriateness including medication errors like drug-drug 
interactions, drug-disease interactions, etc. Polypharmacy may be 
associated with increased risk of adverse drug reactions and a 
decrease in the efficacy of medication because of reduced 
compliance. Increased drug consumption by elderly patients may 
lead to increased prevalence of medication-associated morbidity 
and mortality. The increased cost of drugs with limited resources 
too necessitates the need to audit prescriptions, thereby draw the 
attention of health care providers towards this aspect of prescribing 
quality and appropriateness.  
Most commonly used tool for assessing potential inappropriate 
prescribing in geriatric population is the Beers’ criteria [6]. Previous 
Beers Criteria were updated in 2012 using a comprehensive, 
systematic review and grading of the evidence on drug-related 
problems and adverse drug reactions in older adults. The other tools 
used to assess inappropriate prescribing in geriatric population are 
STOPP (screening tool of older persons’ prescriptions) for detection 
of potential prescribing commission and START (screening tool to 
alert to the right treatment) for detection of potential prescribing 
omission [7]. 
Though the risks of polypharmacy are very clear, it may be 
unavoidable as multiple medications may be needed to cure, slow 
the progression of the disease and prevent its complications. 
Medications may also be needed to reduce the symptoms of the 
disease, thereby improving the quality of life in elderly patients. 
Therefore, balancing the risks and benefits of multiple medications, 
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avoiding inappropriate medications in geriatrics is a major challenge 
for the healthcare providers. In this context, the present study was 
aimed at assessing the prescription quality in a comprehensive 
geriatric clinic and to determine the frequency of inappropriate 
prescription and polypharmacy. 
MATERIALS AND METHODS 
This cross-sectional study was conducted in the geriatric clinic of a 
tertiary care hospital in South India, during the period 2013-14. 
Both male and female patients above the age of 60 y attending a 
geriatric clinic of a tertiary care hospital were included in the study. 
The study protocol was approved by the institutional ethics 
committee. Data regarding patient’s demographics, medical history 
and medication prescribed, were obtained from the patient records 
maintained in the geriatric clinic. The vitamins and minerals that are 
taken on a regular basis, herbal and other alternative medications 
were excluded, as it is difficult to analyse the appropriateness of 
these medications using the standard criteria. After excluding all 
these medications, remaining medications for each patient is 
counted separately. In this study, polypharmacy was considered as 
having 6 or more medications per prescription. Medication 
appropriateness for each patient is analysed separately based on 
their medical history and clinical findings by applying medication 
appropriateness index [8], STOPP [7] & Beer’s criteria [6]. The 
potential prescribing omissions were assessed by START criteria [2]. 
Criteria to assess medication appropriateness 
In this study, inappropriateness was evaluated in three 
categories: Overprescribing (Inappropriate prescription of more 
medications or duplication of medications): This is assessed using 
the Medication Appropriateness Index (MAI) which is a 10 item 
instrument. Three items from MAI was selected (Indication, 
effectiveness, duplication) to assess overprescribing. These three 
items found to have excellent Intra and inter-rater reliability, as 
reported in the previous literature. Based on this assessment, 
medications that are not indicated or ineffective or duplicated are 
counted as overprescribed medications. 
Drugs to be avoided based on Beer’s criteria and STOPP 
criteria: These criteria help to identify drugs to be avoided and 
doses of drug that should not exceed in elderly. These criteria also 
provide information regarding drug-disease and drug-drug 
interactions that should be avoided in elderly. 
Potential prescribing omissions (Under-prescribing): These are 
detected using START criteria. Drugs which are beneficial to the 
patients, but are not being used are identified and listed by 
reviewing the medical history and medication list. 
Sample size: As this is a time-bound cross-sectional study, data 
were collected over a period of 1 y. 
Statistical analysis 
Analyses were done by using SPSS (Statistical Package for the Social 
Sciences) software programme, version 11. All tests were 2-tailed, with 
an α level of 0.05. Data were summarized using descriptive statistics. 
Continuous variables were analyzed using student‘t’ tests and 
categorical variables were compared using chi-square test. Pearson 
correlation was used to correlate with different parameters. 
RESULTS 
A total of 120 patients were included in the study. Among them, 58 
(48.3%) were males, and 62 (51.7%) were females. Mean age of the 
patients was 71.56±6.61 y (60-94 y). Around 82 (68.33%) patients 
had less than 6 prescribed medications and 38 patients (31.66%) 
were on 6 or more than 6 medications. The mean number of 
medications used by the patients was 4.37±2.33 (range 1-12). Table 
1 shows the distribution of patients, according to the number of 
drugs prescribed to them. 
 
Table 1: Distribution of patients based on the number of drugs prescribed 
Number of drugs All patients’ frequency (%) Male patient’s frequency (%) Female patient’s frequency (%) 
1 12 (10) 7 (12.1) 5(8.1) 
2 19 (15.8) 10 (17.2) 9 (14.5) 
3 16 (13.3) 9 (15.5) 7 (11.3) 
4 19 (15.8) 5 (8.6) 14 (22.6) 
5 16 (13.3) 7 (12.1) 9 (14.5) 
6 18 (15) 11 (19) 7 (11.3) 
7 10 (8.3) 7 (12.1) 3 (4.8) 
8 3 (2.5) 1 (1.7) 2 (3.2) 
9 4 (3.3) 1 (1.7) 3 (4.8) 
10 2 (1.7) 7 (12.1) 2 (3.2) 
12 1 (0.8) 0 1 (1.6) 
 
Among 120 patients, 21 (17.5%) were on medications that are not 
indicated, 25 patients (20.83%) were receiving medications which 
are to be avoided in elderly as per the Beer’s and STOPP criteria. 
Medications were underused in 24 patients (20%) as per START 
criteria. When both overused drugs and drugs to be avoided were 
considered for assessment of inappropriateness, 39 patients 
(32.5%) were found to be receiving inappropriate medications. 
Gender-wise comparison did not show statistical significance for 
the proportion of patients receiving an inappropriate prescription 
(table 2).  
 
Table 2: Proportion of patients receiving inappropriate prescriptions 
Groups Drugs to avoid Overprescribing Under use of medications Inappropriate use 
All patients n(%) 25 (20.83) 21 (17.5) 24 (20) 39 (32.5) 
Males n(%) 11 (19) 12 (20.7) 15 (25.9) 20 (34.5) 
Females n(%) 14 (22.6) 9 (14.5) 9 (14.5) 19 (30.6) 




Table 3 shows the comparison of a mean number of medications 
among patients with or without an inappropriate prescription. 
There was a significant difference in the mean number of 
medications among patient with or without drugs to be avoided in 
their prescription (p<0.001). Patients who received drugs to be 
avoided had 5.84±2.41 medications in comparison with those who 
did not have such medications in their prescription. Similar 
observations are seen with regard to the overprescribing and 
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inappropriate use of medications. As expected, patients with 
potential prescribing omissions had less number of medications 
when compared with patients without potential prescribing 
omissions. 
 
Table 3: Comparison of number medications among patients with or without inappropriate prescription 
Groups Number of medications (mean±SD) t value p value Confidence interval 





0.88-2.85 * Absent (n=95) 3.98±2.16 





0.03-3.03 * Absent (n=99) 4.02±2.16 





-1.31-0.81 Absent (n=96) 4.42±2.37 





1.55-3.14 Absent (n=81) 4.02±2.16 
Student ‘t’ test * significant 
 
Table 4 shows the correlation of the number of medications with the 
number of patients receiving drugs to be avoided, overprescribed 
drugs, potential prescribing omissions and inappropriate prescription.  
There was a significant positive correlation between the number 
of medications used and the number of patients receiving drugs to 
be avoided in all patients as well as in females. Over prescribing 
also showed statistically significant positive correlation between 
the number of medications used in all patients as well as in 
females. Potential prescribing omissions have shown a negative 
correlation with the number of medications received, but it is 
statistically insignificant. The combination of drugs to be avoided 
and overprescription was considered as inappropriate use and it 
was showing statistically significant positive correlation with the 
number of medications used in all patients as well as in males and 
females separately. 
Table 5 shows the list of drugs to be avoided (as per Beer’s and 
STOPP criteria) received by patients in this study. Most commonly 
used drug was amitriptyline, which was used in 15 (12.5%) patients. 
 
Table 4: Correlation of prescription quality with the number of medications used 
Groups Correlation coefficient (r) p value 
Drugs to avoid All patients 0.326 <0.01* 
Males 0.212 0.11 
Females 0.409 <0. 01
Overprescribing 
* 




Females 0.427 <0. 01
Potential prescribing omissions 
* 
All patients -0.043 0.64 
Males -0.116 0.38 
Females 0.054 0.68 








Drugs to be avoided 
 significant 
 
Table 5: Patients receiving drugs to be avoided 
Frequency Percentage 
Amitriptyline 15 12.5 
Quetiapine 2 1.67 
Prothiaden 1 0.83 
Prazosin 1 0.83 
Benzodiazepines 3 2.5 
Risperidone 1 0.83 
Trihexyphenidil  2 1.67 
Amiodarone 4 3.33 
Digoxin 1 0.83 
 Table 6 shows the list of drugs overused (assessed by MAI). Two of the patients were receiving more than 2 diuretics. 
 
DISCUSSION 
The present study was aimed at evaluating the quality of 
prescription and proportion of geriatric patients receiving 
polypharmacy at a comprehensive geriatric clinic. Though there is 
no generally accepted consensus on the definition of polypharmacy, 
most studies consider polypharmacy as the use of multiple drugs by 
a single person [9]. In this study, polypharmacy was considered if 
the patient receives>or = 6 concurrent medications. 
Our study has shown polypharmacy in 31.66% of patients. Harugeri 
et al., reported prevalence of polypharmacy (5-9 medications) and 
high-level polypharmacy (more than 10 medications) as 45.0% and 
45.5%, respectively [10]. The lower percentage of polypharmacy in 
the present study could be explained by the fact that we have taken 
criteria for defining polypharmacy as prescription having 6 or more 
medications. The mean number of medications used by our patients 
was 4.37±2.33. The mean number of drugs used by elderly people 
has varied from 3.5 to 6.9 [11-14]. 
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Overprescribing was observed in 17.5% of patients and another 
20.83% of patients were receiving medications which are to be 
avoided in elderly as per the Beer’s and STOPP criteria. 
Inappropriate use was seen in 32.5%, which was assessed by taking 
account of both over-prescription and use of drugs to be avoided. In 
contrast to our findings, Harugeri A et al., reported the prevalence of 
potentially inappropriate prescription use as 23.5% among the 
elderly inpatients in tertiary care hospitals [15]. The present study 
was based on the data collected from outpatients of a geriatric clinic 
in contrast to the above-mentioned inpatient data based study. 
Hence, comparison with this study may not be appropriate. As 
expected, there was a very highly significant difference in the mean 
number of medications among patients having an inappropriate 
prescription and those without the evidence of inappropriateness. 
Correlation analysis also showed significant positive correlation 
between the number of medications used and the number of 
patients receiving an inappropriate prescription. Thus, there is a 
higher chance of inappropriate prescription as the number of 
medications in the prescription increases. Our findings are 
consistent with the previous reports of showing a significant 
association between a number of medications and 
inappropriateness in elderly patients [16, 17]. 
 
Table 6: List of drugs overused (overprescribing) 
Drugs to be avoided Frequency Percentage 
Valproate 2 1.67 
Bethanechol 1 0.83 
Amiodarone 1 0.83 
Digoxin 1 0.83 
Furosemide 1 0.83 
Isosorbide mononitrate 1 0.83 
Quetiapine  2 1.67 
Cinnarizine+betahistine 3 2.5 
Cremaffin+Isphagula 1 0.83 
Ramipril+Rampril hydrochlorothiazide+furosemide+spironolactone Indapamide  1 0.83 
Hydrochlorothiazide+Clonidine-Hydrochlorothiazide+atenolol Indapamide  1 0.83 
Pantaprazole 1 0.83 
Table 7 shows the list of potential prescribing omissions in geriatric patients (as per START criteria). Antihypertensives were the most common 
potential prescribing omissions. 
 
Table 7: Potential prescribing omissions 
Drugs Frequency Percentage 
Hypolipidaemic agents (statins) 2 1.67 
Antiparkinsonian agents 1 0.83 
Antiplatelets 4 3.33 
Antihypertensives 10 8.33 
Antianginal agents 1 0.83 
Drug for GERD 1 0.83 
 
La Hy et al., reported that 62.5% of elderly patients were receiving 
inappropriate medications [18]. They have observed that female 
gender was associated with an increased chance of receiving 
potentially inappropriate medications. In contrast to this study, we 
have observed lower levels of inappropriate prescription in our 
patients and also we did not find gender differences in the 
inappropriate prescription. 
Chung et al., reported inappropriate drug prescriptions using Beers' 
criteria, in 27.8% of elderly inpatients [19]. This is higher than the 
percentage observed in our study. This could be due to the fact that 
only hospitalized pneumonia patients are considered by Chung et al. 
Potential prescribing omissions reviewed using the START criteria 
and were found to be 20%, which was lesser than that seen in a 
study by Lee S-J et al. (26.5%) [20] and in the Ireland study (22.7%) 
[21]. Patients with potential prescribing omissions had less number 
of medications when compared with patients without having 
potential prescribing omissions. Potential prescribing omissions 
have shown a negative correlation with the number of medications 
received, but it is statistically insignificant. Steinman et al., did find 
any differences in potential prescribing omissions in patients taking 
less than five versus five or more medications [22]. 
Antihypertensives were the most common potential prescribing 
omissions followed by antiplatelets and hypolipidaemic agents. The 
START criterion recommends statins for patients with coronary 
artery, cerebrovascular, peripheral vascular disease and diabetics 
with a major risk factor for coronary artery disease, provided that 
they are able to do normal activities of daily life and have a life 
expectancy of more than five years [2]. Steinman et al., also has seen 
that cardiovascular drugs are the most common potential 
prescribing omissions [22]. These drugs proved to be having a major 
effect on morbidity and mortality. Hence, the omission of potentially 
useful medication too needs to be addressed with equal priority to 
that of inappropriate/over prescribing. We need to develop country-
specific clinical practice guidelines for geriatric drug therapy to 
prioritize and balance the use of medications when the patient has 
multiple comorbidities, thereby avoiding the omission of potentially 
useful medications.  
Among the drugs to be avoided, amitriptyline was the most 
commonly used drug in elderly. As per the STOPP & Beer’s criteria, 
tricyclic antidepressants like amitriptyline should be avoided in 
elderly patients. They are highly anticholinergic, sedating and cause 
orthostatic hypotension. Being the cheapest option for painful 
neuropathy, amitriptyline is commonly prescribed for the same even 
in the elderly age group. According to our clinical experience, 
amitriptyline at low dose of 10 mg per day is safe and well tolerated 
in elderly patients. Benzodiazepines also need to be avoided in 
elderly except for some limited situations like ethanol withdrawal, 
severe generalized anxiety, periprocedural anaesthesia, seizure 
disorders, rapid eye movement sleep disorders, end of life care, etc. 
Any type of benzodiazepines should be avoided for treatment of 
insomnia, agitation or delirium. Elderly patients are more sensitive 
to benzodiazepines and have decreased metabolism of long-acting 
benzodiazepines. They increase the risk of cognitive impairment, 
delirium, falls, fractures, etc. Selective alfa1 blockers like prazosin 
should be avoided for the routine treatment of hypertension as it is 
associated with high risk of orthostatic hypotension. Prazosin was 
given as 4th or 5th antihypertensive agent for resistant hypertension. 
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Amiodarone is associated with multiple toxicities. Antiarrhythmic 
drugs are avoided as first-line treatment for atrial fibrillation. 
Evidence suggests that in the elderly population, rate control yields 
the better balance of benefits and harms than rhythm control. 
Amiodarone was used in our patients for control of intermittent 
atrial fibrillation with each episode leading to pulmonary edema. 
Digoxin was used for rate control in cases of atrial fibrillation with 
mitral valve disease. Conventional and atypical antipsychotics 
increase the risk of stroke and mortality in the presence of dementia 
and hence should be avoided for behavioural problems of dementia 
unless non-pharmacological options have failed and the patient is a 
threat to self or others. Quetiapine and risperidone were used in our 
patients for psychosis. Anticholinergics like trihexyphenidyl are not 
recommended for Parkinson’s disease in elderly as the most 
effective agents are available for the same[6].  
Prescribing for elderly patients is more complex as they usually have 
multiple comorbidities. Age-related changes in pharmacokinetics, 
risk of drug-drug/disease interactions adds to the complexity for a 
quality prescription. Prescribing decisions are not always clear cut, 
and clinicians must consider multiple factors. Balancing all these 
issues requires up to date information on standard criteria for 
prescribing in elderly. In this context, the findings of our study may 
provide some insight to improve the quality of prescription for 
elderly patients. 
The strength of our study could be the fact that both the explicit criterion 
(independent of diagnosis) and the implicit criterion (considering 
diagnosis) were applied to assess the appropriateness of prescription by 
using the STOPP/Beers criteria. In addition, in this study potential 
prescription omissions were also identified using the START criteria. 
Some of the limitations of our study need to be considered. Data for 
the analysis collected from a comprehensive geriatric clinic. Hence, it 
may be difficult to extrapolate/generalise the findings to all elderly 
patients, especially those residing in rural settings. The Beer’s criteria, 
as well as STOPP criteria, were developed in western countries. The 
medications listed in these criteria may not have the same adverse 
consequences in different populations of diverse ethnicity. In addition, 
these criteria may have some inherent limitations. Assessment of 
overprescribing was based on some of the relevant questions from the 
Medication Appropriate Index. Though these questions were not 
validated independently as the measure of over-prescribing, many 
authors have used the same in the previous literature. We have 
checked the patient’s medical history and medications only through 
the medical records maintained in the geriatric clinic. As there was no 
direct interaction with the patients, there could be the possibility of 
data being incompletely captured in the medical records.  
CONCLUSION 
Polypharmacy is seen in a significant proportion of geriatric 
patients. The inappropriate prescription is directly proportional to 
the number of medications prescribed. Potential prescribing 
omissions were also observed in a significant proportion of geriatric 
patients, which too needs to be addressed to improve the quality of 
prescription in elderly. 
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